Evolution of the Average Target: Crossject

Evolution of the Average Target - Crossject

Evolution of the Target Price: Crossject

Evolution of the Target Price - Crossject

Changes in Analyst Recommendations: Crossject

91ba546ac758196a5053e7cd68.uSkFrQsYalctV9Ooo7b9fMdW3EDg-8OyNuh2IYr3SbU.93M0zn1uNSUUMqb6msGYTaoaqRavsIn9eKcUSujEG9TVcWTrPlcCJ2Ie6w~6fa011253377308b8df3749db88869a8
12/10 Crossject: No market launch of Zepizure before H127 at best AL
25/09 Crossject: H126. Quid novi sub sole? Not much. AL
26/05 Crossject: The last round of financing? AL
30/03 Crossject: Integrating the FY25 numbers AL
25/03 Crossject: FY25 results: no big change. AL
17/11 Crossject: Yet another round of financing AL
25/25/25 Crossject: Invest Securities Upgrades to 'Buy' Following Successful Capital Increase Zonebourse
09/25/09 Crossject: Here we are for the announced capital increase AL
21/25/21 Crossject: Another capital increase in the pipe… AL
07/25/07 Crossject: Back to life? AL
30/25/30 Crossject: Integrating the FY24 numbers. AL
27/25/27 Crossject: FY24 and outlook: long is the road… AL
10/25/10 Crossject: A complex financing given the amounts involved AL
11/24/11 Crossject: An unsurprising additional financing round. AL
07/24/07 Crossject: H1 24: not yet meaningful AL
25/24/25 Crossject: H1 24: no real surprise, but a glimpse of disappointment AL
17/24/17 Crossject: We are still believers AL
05/24/05 Crossject: Success of the capital increase AL
02/24/02 Crossject: We welcome the securing of the group’s financial needs AL
03/24/03 Crossject: Patience is a virtue… hopefully AL
28/24/28 Crossject: Invest Securities slightly reduces its target Zonebourse
28/24/28 Crossject: Securing the financing needs AL
08/24/08 Crossject: No news is not always good news... AL
06/24/06 Crossject : Marketing initiative in the US AL
03/24/03 Crossject : A new distribution agreement in Northern Europe AL

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +227.8%
+15.09%
+10.41%
+23.06%
+43.42%
+7.85%
+17.74%
+1.21%
+25.9%
+12.11%
Average +38.46%
Weighted average by Cap. +17.75%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.266EUR
Average target price
4.150EUR
Spread / Average Target
+227.80%
High Price Target
4.300EUR
Spread / Highest target
+239.65%
Low Price Target
4.000EUR
Spread / Lowest Target
+215.96%

Analyst Consensus Detail

Analyst consensus - Crossject

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Crossject
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Crossject